PPARG Antikörper (N-Term)
Kurzübersicht für PPARG Antikörper (N-Term) (ABIN2339358)
Target
Alle PPARG Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-30, N-Term
-
Kreuzreaktivität
- Human, Maus
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu Mo
-
Produktmerkmale
- PPARG, NT (PPARG, NR1C3, Peroxisome proliferator-activated receptor gamma, Nuclear receptor subfamily 1 group C member 3)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 1-30 in the N-terminal region of human PPARG, UniProt Accession #P37231.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- PPARG (Peroxisome Proliferator-Activated Receptor gamma (PPARG))
-
Andere Bezeichnung
- PPARG
-
NCBI Accession
- NP_619725
-
UniProt
- P37231
-
Pathways
- MAPK Signalweg, Nuclear Receptor Transcription Pathway, Steroid Hormone Mediated Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, Regulation of Lipid Metabolism by PPARalpha, Positive Regulation of Endopeptidase Activity, Brown Fat Cell Differentiation, Positive Regulation of fat Cell Differentiation
Target
-